Pharmaceutical giants have added $51 billion to their market value in 2020 as they scramble to develop a coronavirus vaccine

Gilead Sciences was the frontrunner among 6 pharma companies helped by its trials of the antiviral medication Remdesivir. Read entire story.

Source: Feedburner